Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
-21.1%/yr
Quarterly compound
Percentile
P62
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 10.91% |
| Q2 2025 | -22.22% |
| Q1 2025 | 6.25% |
| Q4 2024 | -20.00% |
| Q3 2024 | 33.33% |
| Q2 2024 | 63.19% |
| Q1 2024 | 29.74% |
| Q4 2023 | -32.57% |
| Q3 2023 | 62.12% |
| Q2 2023 | -195.85% |
| Q1 2023 | 160.78% |
| Q4 2022 | -23.33% |
| Q3 2022 | 22.25% |
| Q2 2022 | -67.07% |
| Q1 2022 | 77.52% |
| Q4 2021 | -236.18% |
| Q3 2021 | -34.50% |
| Q2 2021 | -4.28% |
| Q1 2021 | 58.75% |
| Q4 2020 | -211.85% |
| Q3 2020 | -28.27% |
| Q2 2020 | 45.26% |
| Q1 2020 | 2.08% |
| Q4 2019 | 15.38% |
| Q3 2019 | -10.44% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |